Plasma suPAR as a prognostic biological marker for ICU mortality in ARDS patients

Intensive Care Medicine

Volumn 41, Issue 7, 2015, Pages 1281-1290

  Geboers, Diederik G P J ^a   de Beer, Friso M ^a   Boer, Anita M Tuip de ^a   van der Poll, Tom ^a   Horn, Janneke ^a   Cremer, Olaf L ^b   Bonten, Marc J M ^b   Ong, David S Y ^b   Schultz, Marcus J ^a   Bos, Lieuwe D J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

ARDS; Biological marker; ICU mortality; suPAR

Indexed keywords

BIOLOGICAL MARKER; UROKINASE RECEPTOR;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ALCOHOL CONSUMPTION; APACHE; ARTICLE; COHORT ANALYSIS; COMORBIDITY; DIABETES MELLITUS; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEART FAILURE; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; LEUKEMIA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; NETHERLANDS; NEW YORK HEART ASSOCIATION CLASS; OUTCOME ASSESSMENT; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL VASCULAR DISEASE; PREDICTIVE VALUE; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SMOKING; TRANSIENT ISCHEMIC ATTACK; BLOOD; CLASSIFICATION; COMPARATIVE STUDY; MIDDLE AGED; MORTALITY; RECEIVER OPERATING CHARACTERISTIC; SEVERITY OF ILLNESS INDEX;

AGED; BIOMARKERS; FEMALE; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; RESPIRATORY DISTRESS SYNDROME, ADULT; ROC CURVE; SEVERITY OF ILLNESS INDEX;

EID: 84933278553     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-015-3924-9     Document Type: Article

References (29)

1. Esteban A, Frutos-Vivar F, Muriel A, Ferguson ND, Peñuelas O, Abraira V et al (2013) Evolution of mortality over time in patients receiving mechanical ventilation. Am J Respir Crit Care Med 188(2):220
2. Erickson SE, Martin GS, Davis JL, Matthay MA, Eisner MD, NIH NHLBI ARDS Network (2009) Recent trends in acute lung injury mortality: 1996–2005. Crit Care Med 37(5):1574
3. Barnett N, Ware LB (2011) Biomarkers in acute lung injury—marking forward progress. Crit Care Clin 27(3):661–683
4. Sapru A, Calfdee CS, Liu KD, Kangelaris K, Hansen H, Pawlikowska L, Ware LB, Alkhouli MF, Abbot J, Matthay MA, The NHLBI ARDS Network (2015) Plasma soluble thrombomodulin levels are associated with mortality in the acute respiratory distress syndrome. Intensive Care Med 41:470–478
5. Thunø M, Machoa B, Eugen-Olsen J (2009) suPAR: the molecular crystal ball. Dis Markers 27:157–172
6. Koch A, Voigt S, Kruschinski C, Sanson E, Dückers H, Horn A, Yagmur E, Zimmermann H, Trautwein C, Tacke F (2011) Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients. Crit Care 15:R63
7. Jalkanen V, Yang R, Linko R, Huhtala H, Okkonen M, Varpula T, Pettila V, Tenhunen J, The FINNALI Study Group (2013) SuPAR and PAI-1 in critically ill, mechanically ventilated patients. Intensive Care Med 39:489–496
8. Suberviola B, Castellanos-Ortega A, Ruiz AR, Lopez-Hoyos M, Santibanez M (2013) Hospital mortality prognostication in sepsis using the new biomarkers suPAR and proADM in a single determination on ICU admission. Intensive Care Med 39:1945–1952
9. Pencina MJ, D’Agostino RB Sr, D’Agostino RB Jr, Vasan RS (2008) Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Statist Med 27:157–172
10. Klein Klouwenberg PM, Ong DS, Bos LD, de Beer FM, van Hooijdonk RT, Huson MA, Straat M, van Vught LA, Wieske L, Horn J, Schultz MJ, van der Poll T, Bonten MJM, Cremer OL (2013) Interobserver agreement of Centers for Disease Control and Prevention criteria for classifying infections in critically ill patients. Crit Care Med 41(10):2373–2378
11. Slutsky S, Ranieri VM (2013) Ventilator-induced lung injury. N Engl J Med 369:2126–2136
12. The National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network (2006) Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 354:2564–2575
13. Dellinger R, Levy M, Carlet J, Bion J, Parker M, Jaeschke R, Reinhart K, Angus D, Brun-Buisson C, Beale R, Calandra T, Dhainaut J, Gerlach H, Harvey M, Marini J, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson B, Townsend S, Vender J, Zimmerman J, Vincent J (2008) Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 36(1):296–327
14. Bernard G, Artigas A, Brigham K, Carlet J, Falke K, Hudson L, Lamy M, LeGall J, Morris A, Spragg R (1994) Report of the American-European consensus conference on acute respiratory distress syndrome: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Consensus Committee. J Crit Care 9(1):72–81
15. ARDS Definition Task Force et al (2012) Acute respiratory distress syndrome: the Berlin definition. JAMA 307(23):2526–2533
16. Ferguson N, Fan E, Camporota L, Antonelli M, Anzueto A, Beale R, Brochard L, Brower R, Esteban A, Gattinoni L, Rhodes A, Slutsky A, Vincent J, Rubenfeld G, Thompson B, Ranieri V (2012) The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material. Intensive Care Med 38(10):1573–1582
17. Zimmerman JE, Kramer AA, McNair DS, Malila FM (2006) Acute Physiology and Chronic Health Evaluation (APACHE) IV: hospital mortality assessment for today’s critically ill patients. Crit Care Med 34(5):1297
18. Vincent JL, de Mendonça A, Cantraine F, Moreno R, Takala J, Suter PM, Sprung CL, Colardyn F, Blecher S (1998) Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on “sepsis-related problems” of the European Society of Intensive Care Medicine. Crit Care Med 26(11):1793–1800
19. Trachsel D, McCrindle BW, Nakagawa S, Bohn D (2005) Oxygenation index predicts outcome in children with acute hypoxemic respiratory failure. Am J Respir Crit Care Med 172:206–211
20. Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, Müller M (2011) pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 12:77
21. R Core Team (2015) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. http://www.R-project.org
22. Plewes K, Royakkers AA, Hanson J, Hasan MM, Alam S, Ghose A, Maude RJ, Stassen PM, Charunwatthana P, Lee SJ, Turner GD, Dondorp AM, Schultz MJ (2014) Correlation of biomarkers for parasite burden and immune activation with acute kidney injury in severe falciparum malaria. Malaria J 13:91
23. Backes Y, van der Sluijs KF, Tuip de Boer AM, Hofstra JJ, Vlaar AP, Determann RM, Knape P, Mackie DP, Schultz MJ (2011) Soluble urokinase-type plasminogen activator receptor levels in patients with burn injuries and inhalation trauma requiring mechanical ventilation: an observational cohort study. Crit Care 15(6):R270
24. Vincent JL, Opal SM, Marshall JC (2010) Ten reasons why we should NOT use severity scores as entry criteria for clinical trials or in our treatment decisions. Crit Care Med 38(1):283–287
25. Quach S, Hennessy DA, Faris P, Fong A, Quan H, Doig C (2009) A comparison between the APACHE II and Charlson Index Score for predicting hospital mortality in critically ill patients. BMC Health Serv Res 30(9):129
26. Ware LB, Koyama T, Billheimer DD, Wu W, Bernard GR, Thompson BT, Brower RG, Standiford TJ, Martin TR, Matthay MA, NHLBI ARDS Clinical Trials Network (2010) Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injury. Chest 137(2):288–296
27. Cook NR (2007) Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 115(7):928–935
28. Pepe MS, Janes H, Longton G, Leisenring W, Newcomb P (2004) Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. Am J Epidemiol 159:882–890
29. Calfee CS, Ware LB, Glidden DV, Eisner MD, Parsons PE, Thompson TB, Matthay MA, National Heart, Blood, and Lung Institute Acute Respiratory Distress Syndrome Network (2011) Use of risk reclassification with multiple biomarkers improves mortality prediction in acute lung injury. Crit Care Med 39:711–717